Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Global Program Leads within the Hematology-Cell Therapy Global Program Leadership organization are strategic-thinking, problem-solving, and action oriented scientific leaders who bring drug development and commercialization insights to drive a sustainable pipeline of innovative medicines. GPLs serve as the “point of accountability” for their assets and are respected, matrix leaders, overseeing multi-disciplinary teams typically responsible for the development of assets from early development (pre-ID3) through commercialization and post-marketing lifecycle management. They will foster a high performing, highly collaborative, truth-seeking team environment aimed at developing and implementing compelling, integrated asset strategies to achieve ambitious near- and long-term portfolio objectives. Each leader is accountable to therapeutic area, R&D, commercial and Company Leadership for: (i) creating a vision and defining the strategy and integrated development plan for each asset within their portfolio, (ii) developing a set of objective criteria against which each asset advancing through the pipeline will be evaluated to enable robust debate and rapid, data-driven decision making; and (iii) ensuring that only high quality and differentiated assets enter the market.Key Responsibilities

Develops and manages product strategy and late drug development program to ensure approval and commercial success

·       Defines and executes the strategic integrated development plan (IDP) in partnership with the cross functional GPT members

·       Participates in regulatory filings (NDA, BLA filings) as well as develops strategy for orphan drug designation

·       Engages with Health Authorities and/or Advisory Committees

·       Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design

·       Builds and maintains collaborative relationships with external stakeholders (Opinion Leaders, Strategic Alliance Partners, Patient Advocacy Leaders, Health Authorities) and appropriately incorporates insights and advice to maximize program impact

·       Actively supports Investor Relations and Public Affairs in managing external BMS communications

Integrates commercialization inputs and deliverables to design the late program strategy that enables approval of a meaningfully differentiated asset with potential to maximize asset value

·       Understands necessary commercial inputs needed to inform the end-to-end development process leading to regulatory approval and successful commercialization 

·       Integrates market inputs (e.g., TPP, DEX/VAP, CI insights) into the integrated development plan, incl., clinical plans and labeling strategy; Appreciates translation of clinical data into claims and considerations for label development

·       Understands and contributes to development of forecasts and investment scenarios, how to assess risk and conduct valuations, and implications for decision making

·       Contributes to the development of brand hallmarks and brand strategy (generic name, brand name, logo, brand colors, positioning, messaging, campaign, segmentation, promotional strategy) understanding the relationship to clinical trial design

·       In partnership with Medical Affairs, supports development of KOL plans and engagements, and leverages KOL input in context of development programs and communicating evidence

·